Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Luca Pastore"'
Publikováno v:
The Scientific World Journal, Vol 10, Pp 2385-2394 (2010)
Celiac disease (CD) is a lifelong, T cell—mediated enteropathy, triggered by the ingestion of gluten and related prolamins in genetically susceptible subjects, resulting in minor intestinal mucosal injury, including villous atrophy with crypt hyper
Externí odkaz:
https://doaj.org/article/6d133ebb7a664d27a0ecf90af07e267e
Publikováno v:
PLoS Medicine, Vol 5, Iss 11, p e212 (2008)
Externí odkaz:
https://doaj.org/article/7252d8e45ef84351ab4d70cbe8b28962
Autor:
M. Tahar Kechadi, Luca Pastore, Fabrizio Marozzo, Loris Belcastro, Domenico Talia, Paolo Trunfio
Publikováno v:
Concurrency and Computation: Practice and Experience. 33
Geotagged data gathered from social media can be used to discover places‐of‐interest (PoIs) that have attracted many visitors. Since a PoI is generally identified by geographical coordinates of a single point, it is hard to match it with people t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd8c08736465393d8b46c136ac33cf2e
https://doi.org/10.1002/cpe.5638
https://doi.org/10.1002/cpe.5638
Autor:
Cristina Bezzio, Marta Vernero, Stefania Costa, Alessandro Armuzzi, Gionata Fiorino, Sandro Ardizzone, Jenny Roselli, Sonia Carparelli, Ambrogio Orlando, Flavio Andrea Caprioli, Fabiana Castiglione, Chiara Viganò, Davide G. Ribaldone, Fabiana Zingone, Rita Monterubbianesi, Nicola Imperatore, Stefano Festa, Marco Daperno, Ludovica Scucchi, Antonio Ferronato, Luca Pastorelli, Eleonora Alimenti, Paola Balestrieri, Chiara Ricci, Maria Cappello, Carla Felice, Francesca Coppini, Patrizia Alvisi, Imma Di Luna, Viviana Gerardi, Angela Variola, Silvia Mazzuoli, Marco Vincenzo Lenti, Simone Saibeni, the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)’s COVID-19 Study Group
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background In Italy, the incidence of SARS-CoV-2 infection peaked in April and November 2020, defining two pandemic waves of coronavirus disease 2019 (COVID-19). This study compared the characteristics and outcomes of patients with inflammat
Externí odkaz:
https://doaj.org/article/a2bb224d7ded48e0a55299be5529046e
Publikováno v:
Journal of Medical Internet Research, Vol 22, Iss 4, p e14979 (2020)
Journal of Medical Internet Research
Journal of Medical Internet Research
Background Current medical professions involve an extensive knowledge of the latest validated scientific data to implement disease diagnosis, therapeutic strategies, and patient care. Although clinicians can refer to a growing number and type of info
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54af65ca49abc89aeb8bd02ab8cc20b0
https://doi.org/10.2196/14979
https://doi.org/10.2196/14979
Autor:
Marco Vincenzo Lenti, Maria Lia Scribano, Livia Biancone, Rachele Ciccocioppo, Daniela Pugliese, Luca Pastorelli, Gionata Fiorino, Edoardo Savarino, Flavio Andrea Caprioli, Sandro Ardizzone, Massimo Claudio Fantini, Gian Eugenio Tontini, Ambrogio Orlando, Gianluca Matteo Sampietro, Giacomo Carlo Sturniolo, Giovanni Monteleone, Maurizio Vecchi, Anna Kohn, Marco Daperno, Renata D’Incà, Gino Roberto Corazza, Antonio Di Sabatino
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), is a complex, immune-mediated, disorder which leads to several gastrointestinal and systemic manifestations determining a poor quality of life, disab
Externí odkaz:
https://doaj.org/article/8d9d88c88d7748329bb4e19831f61bb2
Publikováno v:
Maturitas. 58:102-106
Burning mouth syndrome associated to vulvodynia (Vulvostomatodynia) is a rare condition and is often difficult to diagnose and treat. Tongue, lips, vestibule and others mucosal sites may be affected by a tiresome burning sensation, especially in meno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10991d9e0f76349beb38d7407bd84263
https://doi.org/10.1016/j.maturitas.2007.05.003
https://doi.org/10.1016/j.maturitas.2007.05.003
Autor:
Silvano Gallus, S. Greco, Luca Pastore, F. Parente, S. Bargiggia, Claudia Cucino, G. Bianchi Porro
Publikováno v:
Alimentary Pharmacology & Therapeutics. 17:1503-1506
Summary Background: Acid-suppressive medications are commonly used in hospitalized patients, but, to date, little is known about the overall use of these drugs in the hospital setting. Aim: To evaluate the appropriateness of acid-suppressive therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b8df03b8b246ec5242505baa274bfd1
https://doi.org/10.1046/j.1365-2036.2003.01600.x
https://doi.org/10.1046/j.1365-2036.2003.01600.x
Autor:
Stefano Mazza, Nicole Piazza O. Sed, Francesco Simone Conforti, Alberto Fascì, Alessandro Rimondi, Beatrice Marinoni, Valentina Casini, Chiara Ricci, Francesca Munari, Lorena Pirola, Pietro Invernizzi, Carlo Girelli, Guido Lupinacci, Luca Pastorelli, Flaminia Cavallaro, Luca Ferraris, Alice Colucci, Arnaldo Amato, Gian Eugenio Tontini, Maurizio Vecchi, Gionata Fiorino, Flavio Caprioli
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 1, Pp 172-181 (2022)
Abstract Data regarding double switching from originator infliximab (IFX) to IFX biosimilars in inflammatory bowel diseases (IBDs) are lacking. The purpose of this study was to evaluate the safety and efficacy of switching from originator IFX to CT
Externí odkaz:
https://doaj.org/article/e03578acc9754c6fb34334e43c6266ac
Autor:
Francesca Ferretti, Maria Camilla Monico, Rosanna Cannatelli, Stefania Carmagnola, Marco Vincenzo Lenti, Antonio Di Sabatino, Francesco Conforti, Luca Pastorelli, Flavio Caprioli, Cristina Bezzio, Simone Saibeni, Stefano Mazza, Maurizio Vecchi, Giovanni Maconi, Sandro Ardizzone
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionPatients with inflammatory bowel disease (IBD) have a high risk of developing extra-intestinal manifestations (EIMs). We aimed to assess the cumulative incidence and clinical course of EIMs in patients treated with Vedolizumab (VDZ) and n
Externí odkaz:
https://doaj.org/article/f0a7b803979d42b4bfe8ac61ec4b953d